CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response

This publication has 39 references indexed in Scilit:

• Regulation of CD30 Antigen Expression and Its Potential Significance for Human Disease
  The American Journal of Pathology, 2000
• IL4 production and increased CD30 expression by a unique CD8⁺ T‐cell subset in B‐cell chronic lymphocytic leukaemia
  British Journal of Haematology, 1999
• CD30-Regulated Apoptosis in Murine CD8 T Cells after Cessation of TCR Signals
  Cellular Immunology, 1997
• T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors.
  The Journal of Experimental Medicine, 1996
• CD30-mediated signaling promotes the development of human T helper type 2-like T cells.
  The Journal of Experimental Medicine, 1995
• CD30 ligation induces nuclear factor‐ϰB activation in human T cell lines
  European Journal of Immunology, 1995
• The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
  Cell, 1994
• Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease
  Cell, 1992
• THE EFFECT OF ANTI-L3T4 MONOCLONAL ANTIBODY TREATMENT ON FIRST-SET REJECTION OF MURINE CARDIAC ALLOGRAFTS
  Transplantation, 1987
• Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cells
  Nature, 1982